Prefilled devices for parenteral applications

References

• Adapa RM, Mani V, Murray LJ, et al. Errors during the preparation of drug infusions: a randomized controlled trial. Br J Anaesth 2012;109(5):729-34
   PubMed Web of Science ®Google Scholar
• Makwana S, Basu B, Makasana Y, Dharamsi A. Prefilled syringes: an innovation in parenteral packaging. Int J Pharm Investig 2011;1(4):200-6
   PubMedGoogle Scholar
• CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. CDC, editor. U.S. Department of Health and Human Services; Atlanta, GA: 2011
   Google Scholar
• Psaltopoulou T, Ilias I, Alevizaki M. The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses. Rev Diabet Stud 2010;7(1):26-35
   PubMedGoogle Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine Suspension/Soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27(10):2495-7
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Bell D, Jacobsen C, Suwannasari R. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional Vial/Syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clinical Ther 2003;25(11):2836-46
   PubMed Web of Science ®Google Scholar
• Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4(3):522-31
   PubMedGoogle Scholar
• Eli Lilly and Company. Humalog KwikPen® user manual. 2013
   Google Scholar
• Heinemann L. Insulin pens and new ways of insulin delivery. Diabetes Technol Ther 2013;15(Suppl 1):S48-59
   Google Scholar
• Devroey P, Fauser BC, Diedrich K; Evian Annual Reproduction (EVAR); Workshop Group 2008. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009;15(4):391-408
   PubMed Web of Science ®Google Scholar
• Christansen A, Bentley GE, Cabrera R, et al. Hormonal regulation of female reproduction. Horm Metab Res 2012;44(8):587-91
   PubMed Web of Science ®Google Scholar
• An introduction to epilepsy. In: Bromfield E, Cavazos J, Sirven J, editors. Basic mechanisms underlying seizures and epilepsy. American Epilepsy Society; West Hartford, CT, US: 2006
   Google Scholar
• Christen M, Schertz JC, Arriagada P, et al. The redesigned follitropin α pen injector for infertility treatment. Expert Opin Drug Deliv 2011;8(6):833-9
   PubMed Web of Science ®Google Scholar
• EMD Serono Inc. Gonal-f® RFF Pen User Manual. 2011
   Google Scholar
• National Institutes of Health. Follistim AQ® prescribing information. 1997
   Google Scholar
• Pang SC, Kettel L. Clinical experiences of integrating the Follistim Pen® for the self-administration of follitropin beta into ovarian stimulation treatment regimens. US Obstret Gynecol 2007;20-2
   Google Scholar
• Merck Sharp & Dohme Corp. Elonva® dosage and administration. 2010
   Google Scholar
• Merck and Co Inc. Ganirelix Acetate Injection. 2008
   Google Scholar
• Waters MJ, Hoang HN, Fairlie DP, et al. New insights into growth hormone action. J Mol Endocrinol 2006;36(1):1-7
   PubMed Web of Science ®Google Scholar
• Méndez J, Pásaro E. Turner syndrome: a study of chromosomal mosaicism. Hum Genet 1996;98(1):29-35
   PubMed Web of Science ®Google Scholar
• Dumas H, Panayiotopoulos P, Parker D, Pongpairochana V. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006;6(1):5
   PubMedGoogle Scholar
• Eli Lilly and Company. Humatrope® instructions for use. 2007
   Google Scholar
• Pfizer Inc. Genotropin Pen® instructions for use. 2012
   Google Scholar
• Genentech USA, Inc. Nutropin products and injection devices overview. 2012
   Google Scholar
• Genentech USA, Inc. Nutropin® User Guide. 2013
   Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346(4):257-70
   PubMed Web of Science ®Google Scholar
• Hargreaves RJ, Shepheard S. Pathophysiology of migraine--new insights. Can J Neurol Sci 1999;26(Suppl 3):S12-19
   PubMedGoogle Scholar
• Kalra AA, Elliott D. Acute migraine: current treatment and emerging therapies. Ther Clin Risk Manag 2007;3(3):449-59
   PubMedGoogle Scholar
• Edvinsson L, Villalón C, MaasenVanDenBrink A. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther 2012;136(3):319-33
   PubMed Web of Science ®Google Scholar
• Landy SH, Tepper SJ, Wein T, et al. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Headache 2013;53(1):118-25
   PubMed Web of Science ®Google Scholar
• O’Quinn S, Davis RL, Gutterman D, et al. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia 1999;19(4):223-31
   PubMed Web of Science ®Google Scholar
• Pfizer, Inc. Alsuma® Indications and Usage. 2012
   Google Scholar
• Jasmin L, David Z. Epilepsy. PubMed Health. 2012
   Google Scholar
• Das N, Dhanawat M, Shrivastava SK. An overview on antiepileptic drugs. Drug Discov Ther 2012;6(4):178-93
   PubMedGoogle Scholar
• Chang BS, Lowenstein DH. Epilepsy. N Engl J Med 2003;349(13):1257-66
   PubMed Web of Science ®Google Scholar
• Henriksen O. An overview of benzodiazepines in seizure management. Epilepsia 1998;39(S1):S2-6
   Google Scholar
• Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366(7):591-600
   PubMed Web of Science ®Google Scholar
• Meridian Medical Technologies. Diazepam Autoinjector® instructions. 2005
   Google Scholar
• Reichard DW, Atkinson AJ, Hong PS, et al. Human safety and pharmacokinetic study of intramuscular midazolam administered by autoinjector. J Clin Pharmacol 2010;50(10):1128-35
   PubMed Web of Science ®Google Scholar
• Health Nio. Multiple sclerosis: symptoms, diagnosis, treatment and latest NIH Research. NIH MedlinePlus 2012;7(1):14-15
   Google Scholar
• Kozubski W. Autoinjector improves injection-related tolerability issues in patients with multiple sclerosis – exploring the new ExtaviJectTM 30G system for the injection of interferon beta-1b. Eur Neurol Rev 2010;5(2):77-81
   Google Scholar
• Novartis Pharmaceuticals Corporation. Extravia Injection Training Manual. 2010
   Google Scholar
• Bayer Schering Pharma AG. BetaJect®, Comfort. 2007
   Google Scholar
• EMD Serono, I. Rebiject II®, user manual. 2012
   Google Scholar
• EMD Serono, Inc. EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a). Pfizer Inc, New York, NY; 2013
   Google Scholar
• Meridian Medical Technologies. Morphine auto-injector C-II. 2012
   Google Scholar
• Scott DL, Frederick W, Huizinga TWJ. Rheumatoid arthritis. Lancet 2010;376(9746):1094-108
   PubMed Web of Science ®Google Scholar
• Walker SE, Ranatunga SK. Rheumatoid arthritis: a review. Mo Med 2006;103(5):539-44
   PubMedGoogle Scholar
• American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rehum 2002;46(2):328-46
   PubMedGoogle Scholar
• Zack E. Chemotherapy and biotherapeutic agents for autoimmune diseases. Clin J Oncol Nurs 2012;16(4):E125-32
   PubMedGoogle Scholar
• Kivitz A, Segurado OG. HUMIRA® pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab. Expert Rev Med Devices 2007;4(2):109-16
   PubMed Web of Science ®Google Scholar
• AbbVie Laboratories. Humira® (adalimumab) instructions for use. 2012
   Google Scholar
• Dugdale DC III, Henochowicz S, Zieve D. Anaphylaxis. PubMed Health. 2012
   Google Scholar
• Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ 2003;169(4):307-11
   PubMed Web of Science ®Google Scholar
• Boden SR, Wesley Burks A. Anaphylaxis: a history with emphasis on food allergy. Immunol Rev 2011;242(1):247-57
   PubMedGoogle Scholar
• Simon F, Ram F. Self-injectable adrenaline for anaphylactic emergencies: effectiveness of EpiPen and AnaPen - are they fit for purpose - evidence to date. J Aller Ther 2012;3(1):116
   Google Scholar
• Sunde GA, Heradstveit BE, Vikenes BH, Heltne JK. Emergency intraosseous access in a helicopter emergency medical service: a retrospective study. Scand J Trauma Resusc Emerg Med 2010;18:52
   PubMed Web of Science ®Google Scholar
• Day MW. Intraosseous devices for intravascular access in adult trauma patients. Crit Care Nurse 2011;31(2):76-89
   PubMed Web of Science ®Google Scholar
• US FDA. United States Federal Drug Administration Devices Control and Regulation Handbook. International Publisher Publications, Washington DC, USA; 2010
   Google Scholar
• US FDA. Medical devices; current good manufacturing practice (CGMP) final rule; quality system regulation. Fed Regist 1996;61(195):52602-62
   PubMedGoogle Scholar
• US Department of Health and Human Services, US FDA. Guidance for industry quality systems approach to pharmaceutical CGMP regulations C.f.B.E.a.R.C. Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Office of Regulatory Affairs (ORA), editors. 2006
   Google Scholar
• Friedman LM, Furberg CD, De Mets DL. Fundamentals of clinical trials (Volume 4). 4th edition. Springer; New York, NY: 2010
   Google Scholar
• Sweet BV, Schwemm AK, Parsons DM. Review of the processes for FDA oversight of drugs, medical devices, and combination products. J Manag Care Pharm 2011;17(1):40-50
   PubMed Web of Science ®Google Scholar
• Siegel EB. Development and approval of combination products. 1st edition. Wiley-Interscience; NJ, USA: 2008
   Google Scholar
• U.S. Department of Health and Human Services, US FDA. Guidance for industry and FDA staff: technical considerations for Pen, Jet, and related injectors intended for use with drugs and biological products. 2013
   Google Scholar
• Guo X, Sommavilla B, Vanterpool G, et al. Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals. Expert Opin Drug Deliv 2012;9(4):355-6
   PubMed Web of Science ®Google Scholar
• Macadam C, Barnett J, Roberts G, et al. What factors affect the carriage of epinephrine auto-injectors by teenagers? Clin Transl Allergy 2012;2(1):3
   PubMedGoogle Scholar
• Gluckman PD, Cutfield WS. Evaluation of a pen injector system for growth hormone treatment. Arch Dis Child 1991;66(6):686-8
   PubMed Web of Science ®Google Scholar
• Hayman GR, Bansal JA, Bansal AS. Knowledge about using auto-injectable adrenaline: review of patients’ case notes and interviews with general practitioners. BMJ 2003;327(7427):1328
   PubMedGoogle Scholar